Alta Charo

Alta Charo is an internationally renowned leader in the fields of bioethics and law. She is a Professor Emerita of Law and Bioethics at the University of Wisconsin and is a highly respected voice in the public debate on science policy and new technologies. Her work focuses on the legal and ethical issues that arise from new scientific discoveries, especially in areas like gene editing and reproductive medicine. In 2016, she co-chaired a major committee for the National Academies, which released an important report on the ethical use of human gene editing. Her findings continue to shape policy and public discussion around this powerful technology. A dedicated public servant, Alta served as a senior policy advisor in the Obama administration at the Food and Drug Administration (FDA) from 2009 to 2011. She has also advised numerous other government agencies and expert committees on issues ranging from stem cell research to the ethics of artificial intelligence in medicine. An elected member of the National Academy of Medicine, she has published over 100 articles and reports, making her a trusted authority in her field.